Stocks-NTLA-Intellia Therapeutics Inc

NTLA Intellia Therapeutics Inc

30.85 0.15 (0.49%)
Markt geslotenVertraagde koersen door NASDAQ, in USD
Handelen
Handelen

Intellia Therapeutics Inc prijs

0% Afgelopen week
Marktkapitalisatie
2.77B
Dagbereik
30.60
-
32.32
52W Bereik
22.63
-
47.14
Volume (3M)
1.22M
Prijs-Winstverhouding
-5.78
Inkomsten
51.77M

Intellia Therapeutics Inc Laatste nieuws

Bekijk alle
Top Discussies
David Leslie
Like ReactieDelen
null
.
Tibale23
Guarda il grafico di $NTLA (Intellia Therapeutics Inc) che ho condiviso Vertalen
David Romero Carrasco
We concluded another successful week for our portfolio, achieving a 4.08% increase in value and reaching a 6.03% return this month. With nearly two weeks remaining, attaining our 10% target for the month seems feasible. We need only to achieve 2% each week, which appears more than possible given our... Meer weergeven Vertalen
Like ReactieDelen
null
.
David Romero Carrasco
Today has been excellent, with our portfolio increasing by 3.01% in a single day. This progress puts us on track to reach our monthly target of 10%; currently, we are nearly at 5% for the month. Patience and confidence in my decisions have been instrumental to our success. $WAL (Western Alliance Bancorporation)... Meer weergeven Vertalen
Like ReactieDelen
8 reacties
null
.
DanielIgnasiak
Consultar la página de $NTLA (Intellia Therapeutics Inc) www.etoro.com/es/markets/ntla/ Time to buy... Intellia is poised to initiate a global pivotal study for NTLA-2001 for ATTR-CM by year-end 2023 and is preparing for a Phase 3 study of NTLA-2001 for the treatment of ATTRv-PN. The company also plans... Meer weergeven Vertalen

Voorspelling van analisten

Consensus
Sterke buy
Prijsdoel
93.29

ESG: Een nieuwe bron van inzicht

Krijg inzicht in de duurzaamheid van een bedrijf met behulp van ESG-scores (environmental, social en governance).
0
100
45
Laag
Sector 
Gem. 44 
37
Omgeving
40
Sociaal
54
Bestuur

Mensen kochten ook